Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study.
Elewski BE, Lebwohl MG, Anadkat MJ, Barker J, Ghoreschi K, Imafuku S, Mrowietz U, Li L, Quaresma M, Thoma C, Bachelez H. Elewski BE, et al. Among authors: ghoreschi k. J Am Acad Dermatol. 2023 Jul;89(1):36-44. doi: 10.1016/j.jaad.2023.02.040. Epub 2023 Mar 2. J Am Acad Dermatol. 2023. PMID: 36870370 Free article. Clinical Trial.
Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials.
Blauvelt A, Thaçi D, Papp KA, Ho V, Ghoreschi K, Kim BS, Miller M, Shen YK, You Y, Chan D, Yu J, Yang YW, Lebwohl MG, Gottlieb AB, Crowley J, Foley P. Blauvelt A, et al. Among authors: ghoreschi k. Br J Dermatol. 2023 Jul 7;189(1):132-134. doi: 10.1093/bjd/ljad081. Br J Dermatol. 2023. PMID: 36944555 No abstract available.
Patients' and dermatologists' preferences in artificial intelligence-driven skin cancer diagnostics: A prospective multicentric survey study.
Haggenmüller S, Maron RC, Hekler A, Krieghoff-Henning E, Utikal JS, Gaiser M, Müller V, Fabian S, Meier F, Hobelsberger S, Gellrich FF, Sergon M, Hauschild A, Weichenthal M, French LE, Heinzerling L, Schlager JG, Ghoreschi K, Schlaak M, Hilke FJ, Poch G, Korsing S, Berking C, Heppt MV, Erdmann M, Haferkamp S, Drexler K, Schadendorf D, Sondermann W, Goebeler M, Schilling B, Kather JN, Fröhling S, Kaminski K, Doppler A, Bucher T, Brinker TJ; Collaborators. Haggenmüller S, et al. Among authors: ghoreschi k. J Am Acad Dermatol. 2024 Apr 24:S0190-9622(24)00649-2. doi: 10.1016/j.jaad.2024.04.033. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 38670313 Free article. No abstract available.
Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid.
Solimani F, Mesas-Fernández A, Bodner E, Carevic-Neri M, Hasheminasab M, Jakovljevicova T, Philipp A, Nast A, Worm M, Hilke FJ, Meier K, Ghoreschi K. Solimani F, et al. Among authors: ghoreschi k. J Eur Acad Dermatol Venereol. 2023 Jun;37(6):e695-e697. doi: 10.1111/jdv.18967. Epub 2023 Feb 27. J Eur Acad Dermatol Venereol. 2023. PMID: 36786360 No abstract available.
The Janus kinase 1 inhibitor abrocitinib for the treatment of oral lichen planus.
Solimani F, Mesas-Fernández A, Dilling A, Nast A, Hilke FJ, Ghoreschi FC, Worm M, Ghoreschi K, Meier K. Solimani F, et al. Among authors: ghoreschi fc, ghoreschi k. J Eur Acad Dermatol Venereol. 2023 Mar 27. doi: 10.1111/jdv.19069. Online ahead of print. J Eur Acad Dermatol Venereol. 2023. PMID: 36974430 No abstract available.
Using multiple real-world dermoscopic photographs of one lesion improves melanoma classification via deep learning.
Hekler A, Maron RC, Haggenmüller S, Schmitt M, Wies C, Utikal JS, Meier F, Hobelsberger S, Gellrich FF, Sergon M, Hauschild A, French LE, Heinzerling L, Schlager JG, Ghoreschi K, Schlaak M, Hilke FJ, Poch G, Korsing S, Berking C, Heppt MV, Erdmann M, Haferkamp S, Drexler K, Schadendorf D, Sondermann W, Goebeler M, Schilling B, Kather JN, Krieghoff-Henning E, Brinker TJ. Hekler A, et al. Among authors: ghoreschi k. J Am Acad Dermatol. 2024 May;90(5):1028-1031. doi: 10.1016/j.jaad.2023.11.065. Epub 2024 Jan 8. J Am Acad Dermatol. 2024. PMID: 38199280 Free article. No abstract available.
Upadacitinib for treatment-resistant Lichen amyloidosis.
Solimani F, Dilling A, Ghoreschi FC, Nast A, Ghoreschi K, Meier K. Solimani F, et al. Among authors: ghoreschi fc, ghoreschi k. J Eur Acad Dermatol Venereol. 2023 May;37(5):e633-e635. doi: 10.1111/jdv.18756. Epub 2022 Nov 26. J Eur Acad Dermatol Venereol. 2023. PMID: 36394121 No abstract available.
Federated Learning for Decentralized Artificial Intelligence in Melanoma Diagnostics.
Haggenmüller S, Schmitt M, Krieghoff-Henning E, Hekler A, Maron RC, Wies C, Utikal JS, Meier F, Hobelsberger S, Gellrich FF, Sergon M, Hauschild A, French LE, Heinzerling L, Schlager JG, Ghoreschi K, Schlaak M, Hilke FJ, Poch G, Korsing S, Berking C, Heppt MV, Erdmann M, Haferkamp S, Drexler K, Schadendorf D, Sondermann W, Goebeler M, Schilling B, Kather JN, Fröhling S, Brinker TJ. Haggenmüller S, et al. Among authors: ghoreschi k. JAMA Dermatol. 2024 Mar 1;160(3):303-311. doi: 10.1001/jamadermatol.2023.5550. JAMA Dermatol. 2024. PMID: 38324293 Free PMC article.
192 results